{"id":936515,"date":"2026-02-12T08:21:51","date_gmt":"2026-02-12T13:21:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-02-12T08:21:51","modified_gmt":"2026-02-12T13:21:51","slug":"tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"Tvardi Therapeutics to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>HOUSTON, Feb.  12, 2026  (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that management will participate in the following upcoming investor conferences:<\/p>\n<p>\n        <strong>JonesTrading C-Suite Fireside Chat Series<\/strong><br \/>\n        <br \/>Date: Wednesday, February 19, 2026<br \/>Time: 11:00 AM EST<br \/>Registration Link <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3qF6FUar7GBJ6opcseonSlwlgkjZJtRLDxmRwyCnvpcIFvQrhDq_UEeYMoTFqmJ_RToNq2leh7s2de4g1Om66t7MUrMIdLdJS3FlkISvExcJ1vUYxKfeloaoSjfgve0lQfdOGBB8WVq572i0hg7DjA==\" rel=\"nofollow\" target=\"_blank\">here<\/a><\/p>\n<p>\n        <strong>Oppenheimer 36<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Life Sciences Conference<\/strong><br \/>\n        <br \/>Format: Corporate presentation<br \/>Date: Wednesday, February 25, 2026<br \/>Time: 10:40 AM EST<br \/>Location: Virtual<\/p>\n<p>\n        <strong>TD Cowen 46<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Health Care Conference<\/strong><br \/>\n        <br \/>Format: Corporate presentation<br \/>Date: Tuesday, March 3, 2026<br \/>Time: 1:50 PM EST<br \/>Location: Boston, MA<\/p>\n<p>\n        <strong>Barclays 28<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside chat<br \/>Date: Tuesday, March 10, 2026<br \/>Time: 2:00 PM EST<br \/>Location: Miami Beach, FL<\/p>\n<p>The webcast of the JonesTrading fireside chat and Oppenheimer presentation will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HbsidXax9wiqmr3jNrtsg5EUqffXWjxBSEuaiE0Z9b8n4homsu4MKzGqmBHgsXZuGUmlng2ZRa3deA_kUYb3TjbSdOlwn-QEoFJqGi-Al-288JJQUrRZbvKUU-Xt0Ki_RwPTtvJdlLKYcZ3c1AxAnJAoMBd_BRlSGS5znjFC9Z_sw-zD3kGUpnXlrhPZqm7H11UNGuzDE68tVFOZOBayicIpzyAYiZVfQILLsvYw3aauvjfFdNYysv7xXu_I4scWnjc48NiM-RuzkzGU5UZpiSDUhaP7viNJKRHhEF4eD4LVpRH4bHG7BZn8JTa2jZsbHr2uQnQw0kjS1lN0_lIe0qLJp0lbOvIlo_DFsN8Pv9OEddnuypiQkhvtQoubwr8WEphaBOfR1eGlYelbftql_hhOYEWewTddHWubC_pmYs=\" rel=\"nofollow\" target=\"_blank\">Tvardi Investors\u2019 website<\/a>. A replay of the webcasts will be available for approximately 90 days following the conference.<\/p>\n<p>\n        <strong>About Tvardi Therapeutics<\/strong>\n      <\/p>\n<p>Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting clinical trials with TTI-101 in hepatocellular carcinoma (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eDIOZs7YWDiI6osg4lbAhMYW0JIYIQRPGN6nU6wpmk1hJQtzBgvpaU2xU2yCwkzy8N-o_b4LnxQShMUdD3zwdh7y99BzA2tLZ7ZvlyImIQaU8DwQ7ude_ATys695hUtR\" rel=\"nofollow\" target=\"_blank\">NCT05440708<\/a>) and TTI-109 in healthy volunteers. To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dcIiF0lGCh7GUBhO09RNME_tinnj_5iO7nIGpAtgjnccL4qxdoPjaQfOSGI7CdNwMoQnixg-PEpYcTkPk-qNfvoHnGcln1tHnL2YHTOJ-VA=\" rel=\"nofollow\" target=\"_blank\">tvarditherapeutics.com<\/a> or follow us on LinkedIn and X (Twitter).<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>For Tvardi:<\/strong><br \/>\n        <br \/>Tvardi Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n9CtfBfMKhRSUOnO4ovQMzTde0YaU8shTI4JAnFtm0xd_I5aO7KUTp-ejVOAQJgTnNtsnx4qpYVxTUEOjAnJVg==\" rel=\"nofollow\" target=\"_blank\">ir@tvardi.com<\/a><\/p>\n<p>PJ Kelleher<br \/>LifeSci Advisors<br \/>617-430-7579<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S8L4hYQYBmpvhRu_Ffj357l_ZgaCQvn9JhoHBXD6ZmQvMZhvZhHHpvQBZj4oTwbQlJiHmbDjYYLayUkir7EUvmCVynwhpZd3iN_eESpeAlsFAg-vOdB-sU7aARc7Ns18\" rel=\"nofollow\" target=\"_blank\">pkelleher@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Yzg1MTVlMTQtNGZmNi00ZmJiLTk1NWEtNWE2OTUyYmZjODNlLTUwMDEzMjg0Mi0yMDI2LTAyLTEyLWVu\/tiny\/Tvardi-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that management will participate in the following upcoming investor conferences: JonesTrading C-Suite Fireside Chat Series Date: Wednesday, February 19, 2026Time: 11:00 AM ESTRegistration Link here Oppenheimer 36 th Annual Healthcare Life Sciences Conference Format: Corporate presentationDate: Wednesday, February 25, 2026Time: 10:40 AM ESTLocation: Virtual TD Cowen 46 th Annual Health Care Conference Format: Corporate presentationDate: Tuesday, March 3, 2026Time: 1:50 PM ESTLocation: Boston, MA Barclays 28 th Annual Global Healthcare Conference Format: Fireside chatDate: Tuesday, March 10, 2026Time: 2:00 PM ESTLocation: Miami Beach, FL The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tvardi Therapeutics to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-936515","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that management will participate in the following upcoming investor conferences: JonesTrading C-Suite Fireside Chat Series Date: Wednesday, February 19, 2026Time: 11:00 AM ESTRegistration Link here Oppenheimer 36 th Annual Healthcare Life Sciences Conference Format: Corporate presentationDate: Wednesday, February 25, 2026Time: 10:40 AM ESTLocation: Virtual TD Cowen 46 th Annual Health Care Conference Format: Corporate presentationDate: Tuesday, March 3, 2026Time: 1:50 PM ESTLocation: Boston, MA Barclays 28 th Annual Global Healthcare Conference Format: Fireside chatDate: Tuesday, March 10, 2026Time: 2:00 PM ESTLocation: Miami Beach, FL The &hellip; Continue reading &quot;Tvardi Therapeutics to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T13:21:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tvardi Therapeutics to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-02-12T13:21:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":264,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==\",\"datePublished\":\"2026-02-12T13:21:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tvardi Therapeutics to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that management will participate in the following upcoming investor conferences: JonesTrading C-Suite Fireside Chat Series Date: Wednesday, February 19, 2026Time: 11:00 AM ESTRegistration Link here Oppenheimer 36 th Annual Healthcare Life Sciences Conference Format: Corporate presentationDate: Wednesday, February 25, 2026Time: 10:40 AM ESTLocation: Virtual TD Cowen 46 th Annual Health Care Conference Format: Corporate presentationDate: Tuesday, March 3, 2026Time: 1:50 PM ESTLocation: Boston, MA Barclays 28 th Annual Global Healthcare Conference Format: Fireside chatDate: Tuesday, March 10, 2026Time: 2:00 PM ESTLocation: Miami Beach, FL The &hellip; Continue reading \"Tvardi Therapeutics to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-12T13:21:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tvardi Therapeutics to Participate in Upcoming Investor Conferences","datePublished":"2026-02-12T13:21:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":264,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/","name":"Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==","datePublished":"2026-02-12T13:21:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzE4MyM3NDIxOTQ5IzUwMDEzMjg0Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tvardi Therapeutics to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=936515"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936515\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=936515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=936515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=936515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}